Streptococcus: Notifiable Diseases
The question
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of designating group B Streptococcus as a notifiable disease.
Answered by Ashley Dalton
The UK Health Security Agency (UKHSA) does not recommend adding Group B Streptococcus as a notifiable disease. Existing national surveillance effectively captures Group B Streptococcus infections, monitors trends, and informs antibiotic prescribing policy. The UKHSA has assessed that mandatory notification for Group B Streptococcus would provide no additional public health benefit beyond this.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →